BioAtla, Inc. financial data

Symbol
BCAB on Nasdaq
Location
11085 Torreyana Road, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 183 % -53.2%
Debt-to-equity -503 % -633%
Return On Equity 780 %
Return On Assets -194 % -101%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 58.8M shares +21.6%
Entity Public Float 59.9M USD -34.2%
Common Stock, Value, Issued 6K USD +20%
Weighted Average Number of Shares Outstanding, Basic 58.7M shares +21.5%
Weighted Average Number of Shares Outstanding, Diluted 58.7M shares +21.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Research and Development Expense 47.2M USD -36.3%
General and Administrative Expense 19.1M USD -17.5%
Operating Income (Loss) -66.3M USD +23.1%
Net Income (Loss) Attributable to Parent -64.7M USD +20.9%
Earnings Per Share, Basic -1 USD/shares +32%
Earnings Per Share, Diluted -1 USD/shares +32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.32M USD -85.3%
Assets, Current 9.67M USD -84%
Property, Plant and Equipment, Net 324K USD -64.2%
Operating Lease, Right-of-Use Asset 5.75M USD +654%
Other Assets, Noncurrent 163K USD
Assets 15.9M USD -74.4%
Accounts Payable, Current 5.85M USD +99.8%
Liabilities, Current 18M USD -7.59%
Operating Lease, Liability, Noncurrent 5.01M USD
Liabilities 47.1M USD +20.1%
Retained Earnings (Accumulated Deficit) -536M USD -13.7%
Stockholders' Equity Attributable to Parent -31.2M USD -236%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -31.2M USD -236%
Liabilities and Equity 15.9M USD -74.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.3M USD +47.2%
Net Cash Provided by (Used in) Financing Activities -395K USD -2938%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 58.8M shares +21.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.32M USD -85.3%
Deferred Tax Assets, Valuation Allowance 103M USD +19.9%
Deferred Tax Assets, Gross 103M USD +19.3%
Operating Lease, Liability 6.18M USD +394%
Lessee, Operating Lease, Liability, to be Paid 7.86M USD +519%
Property, Plant and Equipment, Gross 7.68M USD 0%
Operating Lease, Liability, Current 1.17M USD -6.24%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.48M USD +75.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 122K USD -71.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +143%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.68M USD +8726%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.53M USD
Deferred Tax Assets, Operating Loss Carryforwards 33.8M USD +35%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 4.58M USD +27.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.57M USD
Operating Lease, Payments 1.27M USD -17.4%
Additional Paid in Capital 505M USD +2.13%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 183K USD -23.8%
Deferred Tax Assets, Net of Valuation Allowance 183K USD -66.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%